Market Tracker

10/22 3:43am ET

Haemonetics Corp (NYSE:HAE)

34.40
Data as of Oct 21
 +0.22 / +0.64%
Today’s Change
29.86
Today|||52-Week Range
44.20
-18.35%
Year-to-Date
No recent news for Haemonetics Corp.

Today’s Trading

Previous close34.18
Today’s open34.29
Day’s range-- - --
Volume256,613
Average volume (3 months)249,872
Market cap$1.8B
Dividend yield--
Data as of 10/21/2014

Growth & Valuation

Earnings growth (last year)-9.46%
Earnings growth (this year)-13.33%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+5.22%
P/E ratio45.9
Price/Sales1.77
Price/Book2.12

Competitors

 Today’s
change
Today’s
% change
NUVANuVasive Inc+0.44+1.25%
GMEDGlobus Medical Inc+0.02+0.10%
IARTIntegra LifeSciences...+0.72+1.47%
EXASExact Sciences Corp+0.36+1.51%
Data as of 3:59pm ET, 10/21/2014

Financials

Next reporting dateNovember 3, 2014
EPS forecast (this quarter)$0.46
Annual revenue (last year)$938.5M
Annual profit (last year)$35.1M
Net profit margin3.75%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Brian P. Concannon
Chief Financial Officer &
EVP-Business Development
Christopher J. Lindop
Corporate headquarters
Braintree, Massachusetts

Forecasts